While the new coronavirus infection has a major impact on the acceptance of cancer screening, we aim to reduce the burden on medical facilities and the anxiety of the general public as much as possible. We have decided to start a new N-NOSE reception service “Go To N-NOSE” by this fall. You can apply “Go To N-NOSE” directly from our website. As soon as we are ready, we will publish the details on this page and at https://xn--icktbzci4u.com/.
We as HIROTSU Bio Science Inc. (Head Office: Chiyoda-ku, Tokyo; Representative: Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”) are pleas . . .
2024.04.01On March 18, 2024, an reveiw articles on cancer screening by a third-party research team (Romania) was published in "Cancers", an oncology journ . . .
2024.03.29HIROTSU Bioscience Inc. (Head Office: Chiyoda-ku, Tokyo, Representative: Takaaki Hirotsu, hereinafter referred to as “HIROTSU) has verified the . . .
2024.02.29